期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Drug Testing and Analysis LetPub Score 6.2
50 ratings
Rate
Reputation 7.4 Influence 5.0 Speed 7.0 | ||||||||||||||||||||||||||||
期刊簡稱 | DRUG TEST ANAL | ||||||||||||||||||||||||||||
ISSN | 1942-7603 | ||||||||||||||||||||||||||||
E-ISSN | 1942-7611 | ||||||||||||||||||||||||||||
h-index | 44 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 26.90%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611 | ||||||||||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/dta | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | John Wiley and Sons Ltd | ||||||||||||||||||||||||||||
主題領域 | BIOCHEMICAL RESEARCH METHODS | ||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||||||
創刊年 | 2009 | ||||||||||||||||||||||||||||
每年文章數 | 166每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 35.42% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1942-7603%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 3.0 month(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 75% | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Drug Testing and Analysis] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:50:13 評論於 All questions must be answered one by one, no omissions(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:42:21 評論於 It is not necessary to include, but there should be sufficient persuasive reasons for the reviewers and editors(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 10:07:19 評論於 Do reviewers and journal editors require me to supplement the experiment, is it necessary to do it?(0) 讚! | 八坂篷蔚 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 19:05:20 評論於 Should we also respond to reviewers' positive feedback?(0) 讚! | 修然小公主 |
作者: 邻家灵秀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-22 20:33:50 評論於 How long does it take to assign an editor? The submitted article was in the pharmacokinetics category, with submissions from 5-12, revisions from 9-22, acceptance on 11-3, and proof corrections on 11-21(0) 讚! | 邻家灵秀 |
作者: 邻家灵秀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-22 17:34:11 評論於 How long does it take to assign an editor after submission? 158****8231 Posted: I recommend this magazine. The editor-in-chief is very friendly. The magazine does not require page charges or review fees. However, the process from acceptance to publication is lengthy. It took me 10 months(0) 讚! | 邻家灵秀 |
作者: 深渊希哲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-19 23:49:05 評論於 I recommend this magazine. The editor-in-chief is very nice. There are no layout fees or review fees for the magazine. However, the process from submission to publication is lengthy. It took me 10 months(0) 讚! | 深渊希哲 |
作者: Ralap Buckle 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-12-04 19:19:20 評論於 The submitted article is about pharmacokinetics, with submissions from 5-12; revisions from 9-22; acceptance on 11-3; and proof correction on 11-21(0) 讚! | Ralap Buckle |
作者: Ralap Buckle 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-12-04 08:04:42 評論於 The submitted article is in the field of pharmacokinetics, with 5-12 submissions; 9-22 revisions; 11-3 acceptance; 11-21 proof correction(0) 讚! | Ralap Buckle |
作者: Ralap Buckle 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-11-03 22:09:57 評論於 2017-5-12 submission; 2017-9-22 revision; 2017-11-2 acceptance(0) 讚! | Ralap Buckle |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-06-13 22:09:58 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: This professional analysis journal has good quality and the articles published in it are easy to read, with good research significance and value(0) 讚! | 凌霄高洁 |
作者: Isaac McCarthy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-04-02 15:27:43 評論於 This magazine is quite efficient, I submitted an article, it was revised one month later, accepted after another month of revision, then one month of proofreading, and finally half a month online. I hope the payment can be increased a bit(0) 讚! | Isaac McCarthy |
作者: 匿名 領域: 医药科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2013-04-02 12:04:00 評論於 This journal is still very fast, I selectdOne, overhauled one month later, received one month after the revision, then one month proof, then half a month online.I hope that IF can rise again.(0) 讚! | 匿名 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-02-24 11:21:37 評論於 It's a good journal, SCI-E, in my opinion(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-02-24 08:48:57 評論於 It's sci, you can look it up(0) 讚! | 凌霄高洁 |
作者: 陶宁小郎君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-01-30 16:55:50 評論於 Review speed: 1.0 | Submission hit rate: 75.0 Experience sharing: This journal was founded in 2009 and as of 2011 has not been indexed in SCI. Please take note, my friends(0) 讚! | 陶宁小郎君 |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-08-19 21:18:00 評論於 Journal Homepage URL: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611(0) 讚! | 匿名 |
作者: 匿名 領域: 医药科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-05-17 12:59:00 評論於 This journal is a new publication that started publishing in 2009. The reviewers mostly pointed out issues with language rather than scientific content. There’s also a technical check prior to the peer review process. I recommend submitting but pay attention to the formatting requirements when drafting your manuscript. (0) 讚! | 匿名 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us